Recombinant Fowlpox-B7.1 Vaccine
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells. (NCI04) [ ]
Term info
Recombinant Fowlpox-B7.1 Vaccine
- Recombinant Fowlpox-B7.1
- Recombinant Fowlpox-B7.1 Vaccine
- rF-B7.1
- rF-B7.1 Vaccine
NCIT_C116978, NCIT_C128784, NCIT_C116977
CTRP
Recombinant Fowlpox-B7.1 Vaccine
Recombinant_Fowlpox-B7_1_Vaccine
679008
38542
Recombinant Fowlpox-B7.1 Vaccine
Pharmacologic Substance, Virus
C1134569
C2666
Term relations
- Fowlpox Virus Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation